| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/31/2012 | US8105477 System and method for electrochemical detection of biological compounds |
| 01/31/2012 | US8105476 Integrated lancing and measurement device |
| 01/31/2012 | US8104993 Irrigation zone time control |
| 01/31/2012 | US8104533 Spray nozzle apparatus and method of use |
| 01/31/2012 | US8104325 Device for collecting gases in molten metal and measurement method |
| 01/31/2012 | DE20321865U1 Kunststoffwiederaufbereitung mit steuerbarer Dekontamination Plastic reprocessing with controllable decontamination |
| 01/31/2012 | DE202012000159U1 Vorrichtung zum Ansaugen und Transportieren der Emission aus Schornsteinen, um sie messen zu können ohne das Grundstück auf dem die Heizanlage steht betreten zu müssen Device for sucking and transporting the emissions from chimneys to measure they can without the land on which the heating system is having to enter |
| 01/31/2012 | CA2597177C Immunoassay test device and method of use |
| 01/31/2012 | CA2557997C Determination of analyte characteristics based upon binding properties |
| 01/31/2012 | CA2496897C Methods and compositions for modulating xbp-1 activity |
| 01/31/2012 | CA2480747C Integrated sample testing meter |
| 01/31/2012 | CA2474509C Methods and algorithms for cell enumeration in a low-cost cytometer |
| 01/31/2012 | CA2443947C Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 01/31/2012 | CA2411816C Preparing a sample to be analysed from a sample with very large volume |
| 01/31/2012 | CA2393575C Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 01/31/2012 | CA2393251C Eliciting hcv-specific antibodies |
| 01/31/2012 | CA2371658C Method for the identification and/or the quantification of a target compound |
| 01/31/2012 | CA2365780C Carriers having biological substance |
| 01/31/2012 | CA2362908C Kit for radiolabeling proteins with yttrium-90 |
| 01/31/2012 | CA2274989C Cloned glucagon-like peptide-2 receptors |
| 01/31/2012 | CA2274303C Synthetic bi-epitope compounds useful as standard measure in biological dosage of troponin i |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/26/2012 | WO2012012803A2 Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| 01/26/2012 | WO2012012802A2 Neoepitope detection of disease using protein arrays |
| 01/26/2012 | WO2012012801A2 Device for capture, enumeration, and profiling of circulating tumor cells |
| 01/26/2012 | WO2012012800A2 A method and apparatus for detecting the presence of anisotropic crystals and hemozoin producing parasites in liquid blood |
| 01/26/2012 | WO2012012797A2 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 01/26/2012 | WO2012012748A2 Co-coupling to control reactivity of reagents in immunoassays |
| 01/26/2012 | WO2012012747A2 Chemical and physical degradation sensing in oil |
| 01/26/2012 | WO2012012732A2 Sensor for fast detection of e - coli |
| 01/26/2012 | WO2012012719A2 Mass spectrometric methods for quantifying npy 1-36 and npy 3-36 |
| 01/26/2012 | WO2012012717A1 Methods of detecting prenatal or pregnancy-related diseases or conditions |
| 01/26/2012 | WO2012012703A2 Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| 01/26/2012 | WO2012012693A2 Methods for detecting signatures of disease or conditions in bodily fluids |
| 01/26/2012 | WO2012012653A1 Combination therapy with mdm2 and efgr inhibitors |
| 01/26/2012 | WO2012012596A2 Force-induced magnetization contrast for diagnosis and imaging |
| 01/26/2012 | WO2012012595A2 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
| 01/26/2012 | WO2012012571A1 Biolayer interferometry measurement of biological targets |
| 01/26/2012 | WO2012012527A2 Method for linking point of care rapid diagnostic testing results to laboratory-based methods |
| 01/26/2012 | WO2012012500A1 Optical reader systems and lateral flow assays |
| 01/26/2012 | WO2012012499A1 Optical reader system |
| 01/26/2012 | WO2012012469A2 Signal biomarkers |
| 01/26/2012 | WO2012012428A2 Systems and methods for identifying a discontinuity in the boundary of an object in an image |
| 01/26/2012 | WO2012012346A1 Automated analysis of pressurized reservoir fluids |
| 01/26/2012 | WO2012012284A2 Biosensor apparatuses and methods thereof |
| 01/26/2012 | WO2012012232A1 Sound-velocity dewatering system |
| 01/26/2012 | WO2012012225A2 Predicting cancer outcome |
| 01/26/2012 | WO2012012183A2 Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments |
| 01/26/2012 | WO2012012174A1 Sensor housing and reagent chemistry |
| 01/26/2012 | WO2012012171A1 Portable fluorimetric apparatus, method and system |
| 01/26/2012 | WO2012012168A2 Apparatus, system, and method for increasing measurement accuracy in a particle imaging device using light distribution |
| 01/26/2012 | WO2012012019A2 Microsensor for mercury |
| 01/26/2012 | WO2012011952A2 Copy number variant-dependent genes as diagnostic tools, predictive biomarkers and therapeutic targets |
| 01/26/2012 | WO2012011798A2 Detection of formaldehyde |
| 01/26/2012 | WO2012011778A2 Cancer diagnosis kit and pharmaceutical composition for prevention or treatment of cancer |
| 01/26/2012 | WO2012011777A2 Kit for diagnosing colorectal cancer and pharmaceutical composition for prevention or treatment of colorectal cancer |
| 01/26/2012 | WO2012011660A2 Method of manufacturing micro chamber plate with built-in sample and analytic micro chamber plate, analytic micro chamber plate and apparatus set for manufacturing analytic micro chamber plate with built-in sample |
| 01/26/2012 | WO2012011610A1 Method for inducing differentiation of human pluripotent stem cell into intermediate mesoderm cell |
| 01/26/2012 | WO2012011563A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | WO2012011556A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | WO2012011554A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | WO2012011494A1 Method for measuring crispness of food product |
| 01/26/2012 | WO2012011485A1 Method for prediction of therapeutic effect of chemotherapy on breast cancer patient |
| 01/26/2012 | WO2012011477A1 Magnetic-field measurement device |
| 01/26/2012 | WO2012011144A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom. |
| 01/26/2012 | WO2012010881A1 Competition assay |
| 01/26/2012 | WO2012010875A2 Diagnostic reagents |
| 01/26/2012 | WO2012010864A1 Method and device for determining an oxydant in an aqueous solution |
| 01/26/2012 | WO2012010811A1 Method and device for analysing molecular interactions, and uses thereof |
| 01/26/2012 | WO2012010806A1 Method and device for detecting trace amounts of many gases |
| 01/26/2012 | WO2012010787A1 Apparatus and method for the automated detection of phases for automated analysis |
| 01/26/2012 | WO2012010736A1 Antifreeze concentration conductivity measuring device |
| 01/26/2012 | WO2012010728A1 Biomarker for cancer diagnosis, prognosis and follow-up |
| 01/26/2012 | WO2012010696A1 Methods for cancer management targeting co-029 |
| 01/26/2012 | WO2012010677A1 Diagnostic method for assaying anti-srp antibodies |
| 01/26/2012 | WO2012010666A1 Magnetic immunodiagnostic methods and kits for the demonstration of antibody/antigen complexes in erythrocyte blood grouping and phenotyping |
| 01/26/2012 | WO2012010661A1 Methods for determining a prognosis for survival for a patient with leukaemia |
| 01/26/2012 | WO2012010654A2 Immmunomagnetic complex and its use in red blood cell grouping/phenotyping |
| 01/26/2012 | WO2012010653A1 Method for hydrophilizing surfaces of fluidic components and parts containing such components |
| 01/26/2012 | WO2012010552A1 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 01/26/2012 | WO2012010551A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | WO2012010550A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | WO2012010549A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | WO2012010548A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | WO2012010547A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/26/2012 | WO2012010546A1 Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer |
| 01/26/2012 | WO2012010308A1 Zwitterion buffer containing compositions and uses in electroanalytical devices and methods |
| 01/26/2012 | WO2012010281A1 Measuring device for exhaust gas measurement |
| 01/26/2012 | WO2012010251A1 Method of performing an assay |
| 01/26/2012 | WO2012010240A1 In vivo method for the evaluation of a compound-target interaction |
| 01/26/2012 | WO2012010176A1 Bioassay for the measurement of cepo concentration and activity |
| 01/26/2012 | WO2012010105A1 Methods for detection of lethal system |
| 01/26/2012 | WO2012009798A1 Molecular diagnosis of antibody mediated rejection |
| 01/26/2012 | WO2011154570A9 Ghrelin variant and uses thereof |
| 01/26/2012 | WO2011151825A3 Diagnosis of cancer |
| 01/26/2012 | WO2011150517A3 Xyxin fragment biomarker for diagnosis of colon cancer |
| 01/26/2012 | WO2011150509A3 Diagnosing asthma based on pentraxin-3 |
| 01/26/2012 | WO2011149947A3 Methods of determining amyloid beta turnover in blood |
| 01/26/2012 | WO2011147017A3 System and method for extracting features in a medium from data having spatial coordinates |
| 01/26/2012 | WO2011129526A3 Noninvasive method and apparatus for screening high-quality seeds |